Bone health history in breast cancer patients on aromatase inhibitors.

Bone health history in breast cancer patients on aromatase inhibitors.

A cross-sectional study was performed to assess bone health history among aromatase inhibitor (AI) users before breast cancer (BC) diagnosis, which may impact fracture risk after AI therapy and choice of initial hormonal therapy. A total of 2,157 invasive BC patients initially treated with an AI wer...

Full description

Bibliographic Details
Main Authors: Marilyn L Kwan, Joan C Lo, Li Tang, Cecile A Laurent, Janise M Roh, Malini Chandra, Theresa E Hahn, Chi-Chen Hong, Lara Sucheston-Campbell, Dawn L Hershman, Charles P Quesenberry, Christine B Ambrosone, Lawrence H Kushi, Song Yao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4213031?pdf=render

Internet

http://europepmc.org/articles/PMC4213031?pdf=render

Similar Items